These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7788856

  • 1. Effect of three tumour promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-beta 1.
    Oberhammer FA, Qin HM.
    Carcinogenesis; 1995 Jun; 16(6):1363-71. PubMed ID: 7788856
    [Abstract] [Full Text] [Related]

  • 2. EGF- and CPA-induced mitogenic stimuli are differentially down-regulated by TGF-beta1 in cultured rat hepatocytes.
    Fasciati R, Maier P.
    Carcinogenesis; 1997 May; 18(5):911-7. PubMed ID: 9163675
    [Abstract] [Full Text] [Related]

  • 3. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
    James NH, Roberts RA.
    Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
    [Abstract] [Full Text] [Related]

  • 4. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
    Bayly AC, Roberts RA, Dive C.
    J Cell Biol; 1994 Apr; 125(1):197-203. PubMed ID: 8138571
    [Abstract] [Full Text] [Related]

  • 5. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
    Strange J, Roberts RA.
    Mutat Res; 1996 Nov 11; 372(1):107-13. PubMed ID: 9003537
    [Abstract] [Full Text] [Related]

  • 6. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH, Roberts RA.
    Carcinogenesis; 1994 Dec 11; 15(12):2687-94. PubMed ID: 8001222
    [Abstract] [Full Text] [Related]

  • 7. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor beta 1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation.
    Oberhammer F, Nagy P, Tiefenbacher R, Fröschl G, Bouzahzah B, Thorgeirsson SS, Carr B.
    Hepatology; 1996 Feb 11; 23(2):329-37. PubMed ID: 8591860
    [Abstract] [Full Text] [Related]

  • 8. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
    Hasmall SC, West DA, Olsen K, Roberts RA.
    Carcinogenesis; 2000 Dec 11; 21(12):2159-65. PubMed ID: 11133804
    [Abstract] [Full Text] [Related]

  • 9. Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters.
    Parzefall W, Erber E, Sedivy R, Schulte-Hermann R.
    Cancer Res; 1991 Feb 15; 51(4):1143-7. PubMed ID: 1705168
    [Abstract] [Full Text] [Related]

  • 10. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
    West DA, James NH, Cosulich SC, Holden PR, Brindle R, Rolfe M, Roberts RA.
    Hepatology; 1999 Dec 15; 30(6):1417-24. PubMed ID: 10573520
    [Abstract] [Full Text] [Related]

  • 11. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
    Hasmall SC, James NH, Macdonald N, Gonzalez FJ, Peters JM, Roberts RA.
    Mutat Res; 2000 Mar 17; 448(2):193-200. PubMed ID: 10725472
    [Abstract] [Full Text] [Related]

  • 12. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
    Gerbracht U, Bursch W, Kraus P, Putz B, Reinacher M, Timmermann-Trosiener I, Schulte-Hermann R.
    Carcinogenesis; 1990 Apr 17; 11(4):617-24. PubMed ID: 1691053
    [Abstract] [Full Text] [Related]

  • 13. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.
    Roberts RA, Soames AR, Gill JH, James NH, Wheeldon EB.
    Carcinogenesis; 1995 Aug 17; 16(8):1693-8. PubMed ID: 7634391
    [Abstract] [Full Text] [Related]

  • 14. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.
    Chevalier S, Macdonald N, Tonge R, Rayner S, Rowlinson R, Shaw J, Young J, Davison M, Roberts RA.
    Eur J Biochem; 2000 Aug 17; 267(15):4624-34. PubMed ID: 10903494
    [Abstract] [Full Text] [Related]

  • 15. Responsiveness of hepatocytes to epidermal growth factor, transforming growth factor-beta and norepinephrine during treatment with xenobiotic hepatic tumor promoters.
    Tsai WH, Michalopoulos GK.
    Cancer Lett; 1991 Apr 17; 57(1):83-90. PubMed ID: 1709063
    [Abstract] [Full Text] [Related]

  • 16. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens.
    Christensen JG, Gonzales AJ, Cattley RC, Goldsworthy TL.
    Cell Growth Differ; 1998 Sep 17; 9(9):815-25. PubMed ID: 9751125
    [Abstract] [Full Text] [Related]

  • 17. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia.
    Grasl-Kraupp B, Rossmanith W, Ruttkay-Nedecky B, Müllauer L, Kammerer B, Bursch W, Schulte-Hermann R.
    Hepatology; 1998 Sep 17; 28(3):717-26. PubMed ID: 9731564
    [Abstract] [Full Text] [Related]

  • 18. Long-term treatment with hepatic tumor promoters inhibits mitogenic responses of hepatocytes to acidic fibroblast growth factor and hepatocyte growth factor.
    Tsai WH, Zarnegar R, Michalopoulos GK.
    Cancer Lett; 1991 Aug 17; 59(2):103-8. PubMed ID: 1715812
    [Abstract] [Full Text] [Related]

  • 19. Responsiveness of hepatocytes from dichloroacetic acid or phenobarbital treated mice to growth factors in primary culture.
    Tsai WH, DeAngelo AB.
    Cancer Lett; 1996 Feb 06; 99(2):177-83. PubMed ID: 8616822
    [Abstract] [Full Text] [Related]

  • 20. Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-beta 1 occurs without activation of an endonuclease.
    Oberhammer F, Fritsch G, Pavelka M, Froschl G, Tiefenbacher R, Purchio T, Schulte-Hermann R.
    Toxicol Lett; 1992 Dec 06; 64-65 Spec No():701-4. PubMed ID: 1335183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.